The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Pulmonary Disease, Chronic Obstructive

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Pulmonary Disease, Chronic Obstructive


Psychiatry related information on Pulmonary Disease, Chronic Obstructive


High impact information on Pulmonary Disease, Chronic Obstructive


Chemical compound and disease context of Pulmonary Disease, Chronic Obstructive


Biological context of Pulmonary Disease, Chronic Obstructive


Anatomical context of Pulmonary Disease, Chronic Obstructive


Gene context of Pulmonary Disease, Chronic Obstructive


Analytical, diagnostic and therapeutic context of Pulmonary Disease, Chronic Obstructive


  1. Clinical use of the total artificial heart. DeVries, W.C., Anderson, J.L., Joyce, L.D., Anderson, F.L., Hammond, E.H., Jarvik, R.K., Kolff, W.J. N. Engl. J. Med. (1984) [Pubmed]
  2. Association of noninvasive ventilation with nosocomial infections and survival in critically ill patients. Girou, E., Schortgen, F., Delclaux, C., Brun-Buisson, C., Blot, F., Lefort, Y., Lemaire, F., Brochard, L. JAMA (2000) [Pubmed]
  3. Atrial natriuretic factor in chronic obstructive lung disease with pulmonary hypertension. Physiological correlates and response to peptide infusion. Adnot, S., Andrivet, P., Chabrier, P.E., Piquet, J., Plas, P., Braquet, P., Roudot-Thoraval, F., Brun-Buisson, C. J. Clin. Invest. (1989) [Pubmed]
  4. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Smith, C.A., Harrison, D.J. Lancet (1997) [Pubmed]
  5. Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Hospers, J.J., Postma, D.S., Rijcken, B., Weiss, S.T., Schouten, J.P. Lancet (2000) [Pubmed]
  6. Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. Wagena, E.J., Knipschild, P.G., Huibers, M.J., Wouters, E.F., van Schayck, C.P. Arch. Intern. Med. (2005) [Pubmed]
  7. Long-term effects of almitrine bismesylate on oxygenation during wakefulness and sleep in chronic obstructive pulmonary disease. Gothe, B., Cherniack, N.S., Bachand, R.T., Szalkowski, M.B., Bianco, K.A. Am. J. Med. (1988) [Pubmed]
  8. Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders. Papp, L.A., Weiss, J.R., Greenberg, H.E., Rifkin, A., Scharf, S.M., Gorman, J.M., Klein, D.F. The American journal of psychiatry. (1995) [Pubmed]
  9. Concurrent use of theophylline and lithium in a patient with chronic obstructive lung disease and bipolar disorder. Sierles, F.S., Ossowski, M.G. The American journal of psychiatry. (1982) [Pubmed]
  10. Nocturnal saturation improves by target-flow inspiratory muscle training in patients with COPD. Heijdra, Y.F., Dekhuijzen, P.N., van Herwaarden, C.L., Folgering, H.T. Am. J. Respir. Crit. Care Med. (1996) [Pubmed]
  11. Inhaled triamcinolone and chronic obstructive pulmonary disease. De Maria, A., Canonica, G.W. N. Engl. J. Med. (2001) [Pubmed]
  12. Contractile properties of the human diaphragm during chronic hyperinflation. Similowski, T., Yan, S., Gauthier, A.P., Macklem, P.T., Bellemare, F. N. Engl. J. Med. (1991) [Pubmed]
  13. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. Dinh-Xuan, A.T., Higenbottam, T.W., Clelland, C.A., Pepke-Zaba, J., Cremona, G., Butt, A.Y., Large, S.R., Wells, F.C., Wallwork, J. N. Engl. J. Med. (1991) [Pubmed]
  14. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease. Murciano, D., Auclair, M.H., Pariente, R., Aubier, M. N. Engl. J. Med. (1989) [Pubmed]
  15. Atopy and airways responsiveness in chronic obstructive pulmonary disease. Weiss, S.T. N. Engl. J. Med. (1987) [Pubmed]
  16. Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. Woodcock, A.A., Gross, E.R., Gellert, A., Shah, S., Johnson, M., Geddes, D.M. N. Engl. J. Med. (1981) [Pubmed]
  17. The effect of terbutaline on cardiac function in patients with stable chronic obstructive lung disease. Sunderrajan, E.V., Byron, W.A., McKenzie, W.N., Hurst, D.J., Allegro, M.M., Thakur, V.M., Holmes, R.A. JAMA (1983) [Pubmed]
  18. Bronchodilator effects on gastric acid secretion. Foster, L.J., Trudeau, W.L., Goldman, A.L. JAMA (1979) [Pubmed]
  19. Selection of patients with chronic obstructive pulmonary disease for long-term oxygen therapy. Timms, R.M., Kvale, P.A., Anthonisen, N.R., Boylen, C.T., Cugell, D.W., Petty, T.L., Williams, G.W. JAMA (1981) [Pubmed]
  20. Mechanisms underlying CO2 retention during flow-resistive loading in patients with chronic obstructive pulmonary disease. Oliven, A., Kelsen, S.G., Deal, E.C., Cherniack, N.S. J. Clin. Invest. (1983) [Pubmed]
  21. Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD. Löfdahl, C.G., Postma, D.S., Pride, N.B., Boe, J., Thorén, A. Eur. Respir. J. (2007) [Pubmed]
  22. Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study. Bathoorn, E., Slebos, D.J., Postma, D.S., Koeter, G.H., van Oosterhout, A.J., van der Toorn, M., Boezen, H.M., Kerstjens, H.A. Eur. Respir. J. (2007) [Pubmed]
  23. Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients. Araya, J., Cambier, S., Markovics, J.A., Wolters, P., Jablons, D., Hill, A., Finkbeiner, W., Jones, K., Broaddus, V.C., Sheppard, D., Barzcak, A., Xiao, Y., Erle, D.J., Nishimura, S.L. J. Clin. Invest. (2007) [Pubmed]
  24. Effect of negative pressure ventilation in severe chronic obstructive pulmonary disease. Shapiro, S.H., Ernst, P., Gray-Donald, K., Martin, J.G., Wood-Dauphinee, S., Beaupré, A., Spitzer, W.O., Macklem, P.T. Lancet (1992) [Pubmed]
  25. Research applications and implications of adenosine in diseased airways. Spicuzza, L., Bonfiglio, C., Polosa, R. Trends Pharmacol. Sci. (2003) [Pubmed]
  26. Effect of digoxin on right ventricular function in severe chronic airflow obstruction. A controlled clinical trial. Mathur, P.N., Powles, P., Pugsley, S.O., McEwan, M.P., Campbell, E.J. Ann. Intern. Med. (1981) [Pubmed]
  27. Losartan reduces hematocrit in patients with chronic obstructive pulmonary disease and secondary erythrocytosis. Vlahakos, D.V., Marathias, K.P., Kosmas, E.N. Ann. Intern. Med. (2001) [Pubmed]
  28. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Brightling, C.E., Monteiro, W., Ward, R., Parker, D., Morgan, M.D., Wardlaw, A.J., Pavord, I.D. Lancet (2000) [Pubmed]
  29. A novel, potent dual inhibitor of the leukocyte proteases cathepsin G and chymase: molecular mechanisms and anti-inflammatory activity in vivo. de Garavilla, L., Greco, M.N., Sukumar, N., Chen, Z.W., Pineda, A.O., Mathews, F.S., Di Cera, E., Giardino, E.C., Wells, G.I., Haertlein, B.J., Kauffman, J.A., Corcoran, T.W., Derian, C.K., Eckardt, A.J., Damiano, B.P., Andrade-Gordon, P., Maryanoff, B.E. J. Biol. Chem. (2005) [Pubmed]
  30. Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapy. Patel, H.J., Belvisi, M.G., Bishop-Bailey, D., Yacoub, M.H., Mitchell, J.A. J. Immunol. (2003) [Pubmed]
  31. Pulmonary effect of amiodarone in patients with heart failure. The Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy (CHF-STAT) Investigators (Veterans Affairs Cooperative Study No. 320). Singh, S.N., Fisher, S.G., Deedwania, P.C., Rohatgi, P., Singh, B.N., Fletcher, R.D. J. Am. Coll. Cardiol. (1997) [Pubmed]
  32. Low-dose acetazolamide does affect respiratory muscle function in spontaneously breathing anesthetized rabbits. Kiwull-Schöne, H.F., Teppema, L.J., Kiwull, P.J. Am. J. Respir. Crit. Care Med. (2001) [Pubmed]
  33. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. Ito, K., Yamamura, S., Essilfie-Quaye, S., Cosio, B., Ito, M., Barnes, P.J., Adcock, I.M. J. Exp. Med. (2006) [Pubmed]
  34. Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma. Wallaert, B., Desreumaux, P., Copin, M.C., Tillie, I., Benard, A., Colombel, J.F., Gosselin, B., Tonnel, A.B., Janin, A. J. Exp. Med. (1995) [Pubmed]
  35. The transforming growth factor-beta1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD). Celedón, J.C., Lange, C., Raby, B.A., Litonjua, A.A., Palmer, L.J., DeMeo, D.L., Reilly, J.J., Kwiatkowski, D.J., Chapman, H.A., Laird, N., Sylvia, J.S., Hernandez, M., Speizer, F.E., Weiss, S.T., Silverman, E.K. Hum. Mol. Genet. (2004) [Pubmed]
  36. Cytokine-directed therapies for the treatment of chronic airway diseases. Barnes, P.J. Cytokine Growth Factor Rev. (2003) [Pubmed]
  37. Activation of discoidin domain receptor 1 on CD14-positive bronchoalveolar lavage fluid cells induces chemokine production in idiopathic pulmonary fibrosis. Matsuyama, W., Watanabe, M., Shirahama, Y., Oonakahara, K., Higashimoto, I., Yoshimura, T., Osame, M., Arimura, K. J. Immunol. (2005) [Pubmed]
  38. The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. Zhu, G., Warren, L., Aponte, J., Gulsvik, A., Bakke, P., Anderson, W.H., Lomas, D.A., Silverman, E.K., Pillai, S.G. Am. J. Respir. Crit. Care Med. (2007) [Pubmed]
  39. Modification of surface antigens in blood CD8+ T-lymphocytes in COPD: effects of smoking. Koch, A., Gaczkowski, M., Sturton, G., Staib, P., Schinköthe, T., Klein, E., Rubbert, A., Bacon, K., Wassermann, K., Erdmann, E. Eur. Respir. J. (2007) [Pubmed]
  40. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Dahl, M., Vestbo, J., Lange, P., Bojesen, S.E., Tybjaerg-Hansen, A., Nordestgaard, B.G. Am. J. Respir. Crit. Care Med. (2007) [Pubmed]
  41. The clinical utility of biomarkers in asthma and COPD. Snell, N., Newbold, P. Curr. Opin. Pharmacol (2008) [Pubmed]
  42. Identification of pendrin as a common mediator for mucus production in bronchial asthma and chronic obstructive pulmonary disease. Nakao, I., Kanaji, S., Ohta, S., Matsushita, H., Arima, K., Yuyama, N., Yamaya, M., Nakayama, K., Kubo, H., Watanabe, M., Sagara, H., Sugiyama, K., Tanaka, H., Toda, S., Hayashi, H., Inoue, H., Hoshino, T., Shiraki, A., Inoue, M., Suzuki, K., Aizawa, H., Okinami, S., Nagai, H., Hasegawa, M., Fukuda, T., Green, E.D., Izuhara, K. J. Immunol. (2008) [Pubmed]
  43. Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. Saint, S., Bent, S., Vittinghoff, E., Grady, D. JAMA (1995) [Pubmed]
  44. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lacasse, Y., Wong, E., Guyatt, G.H., King, D., Cook, D.J., Goldstein, R.S. Lancet (1996) [Pubmed]
  45. The association between the quality of inpatient care and early readmission. Ashton, C.M., Kuykendall, D.H., Johnson, M.L., Wray, N.P., Wu, L. Ann. Intern. Med. (1995) [Pubmed]
  46. The effect of almitrine bismesylate on hypoxemia in chronic obstructive pulmonary disease. Bell, R.C., Mullins, R.C., West, L.G., Bachand, R.T., Johanson, W.G. Ann. Intern. Med. (1986) [Pubmed]
WikiGenes - Universities